“Evidence Level for Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Respectively Sodium Glucose Co-Transporter-2 Inhibitors for Mitochondrial Diabetes Is Low”. 2020. Innovative Journal of Medical and Health Sciences 10 (06): 959-60. http://www.innovativejournal.in/index.php/ijmhs/article/view/2988.